Close

News

Promising Future for Asian Entrepreneurship as the Winners of the 14th Annual FedEx / JA International Trade Challenge Competition are Announced

FedEx Express, a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, together with Junior Achievement (JA) Asia Pacific, announced the student winners of the 2020-2021 edition of its annual FedEx Express / JA International...

Recipharm names 2020 International Environmental Award winner

Global contract development and manufacturing organisation (CDMO), Recipharm has announced its 2020 International Environmental Award will be presented to Dr. Amy Pruden, Professor of Civil and Environmental Engineering at Virginia Tech in Blacksburg, Virginia, USA. Dr. Pruden is widely recognised...

Regeneron Announces Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma

Regeneron Pharmaceuticals, Inc. announced detailed results from a Phase 2 proof-of-concept trial evaluating the investigational antibody cocktail REGN1908-1909 in cat-allergic patients with mild asthma. The trial met the primary endpoint of preventing early asthma reactions (EAR, defined as a...

Cainiao and Saudia Cargo team up on China-Europe flights

Cainiao Smart Logistics Network, and Saudia Cargo are teaming up on five weekly flights from Hong Kong to Liege in Belgium, with Riyadh city as a connection point. The partnership, which starts today, aims to form a sky bridge linking...

Cathay Cargo transports multiple types of Covid vaccines

Cathay Pacific Cargo is using its Vaccine Solution pharma service to transport large numbers of Covid-19 vaccines, under varying required conditions, to destinations in its network. Yesterday, the carrier carried 1m vaccine doses manufactured by Fosun Pharma/BioNTech from Frankfurt to...

Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19

The U.S. government has agreed to purchase a minimum of 100,000 doses of bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together, Eli Lilly and Company announced. Bamlanivimab and etesevimab together recently received emergency use authorization for the...

Junshi Biosciences, AstraZeneca enter collaboration to commercialize toripalimab in China

Junshi Biosciences, a leading innovation-driven biopharmaceutical company, announced that the company has entered into an exclusive promotion agreement with AstraZeneca Pharmaceutical Co., Ltd, pursuant to which Junshi Biosciences will grant AstraZeneca Pharmaceutical the exclusive promotion right of toripalimab in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »